74290-69-0

Usage

Uses

Used in Flavoring Industry:
2-AMINO-5-BROMO-6-METHYLPYRAZINE is used as a flavoring agent for its distinctive strong, savory, and slightly earthy aroma, contributing to the enhancement of taste profiles in various food and beverage products.
Used in Pharmaceutical Research:
2-AMINO-5-BROMO-6-METHYLPYRAZINE is studied for its potential pharmacological activities, including its anti-cancer properties, making it a candidate for further research and development in the pharmaceutical industry.
Used in Anti-Microbial Applications:
2-AMINO-5-BROMO-6-METHYLPYRAZINE has also been investigated for its anti-microbial properties, suggesting its possible use in applications requiring microbial control, such as in the development of antimicrobial agents or treatments.

InChI:InChI=1/C5H6BrN3/c1-3-5(6)8-2-4(7)9-3/h2H,1H3,(H2,7,9)

Upstream product

• 5521-56-2 6-methylpyrazin-2-amine 
• 930798-25-7 2-(6-chloropyrazin-2-yl)acetic acid 
• 930798-26-8 2-(6-chloro-pyrazin-2-yl)-malonic acid diethyl ester 
• 38557-71-0 2-chloro-6-methylpyrazine 
• 6761-50-8 2-amino-6-methylpyrazine-3-carboxylic acid 

Downstream Products

• 1374651-65-6 5-amino-3-methylpyrazine-2-carbonitrile 

Relevant academic research and scientific papers

ANTIDIABETIC BICYCLIC COMPOUNDS

Novel compounds of the structural formula (I), and the pharmaceutically acceptable salts thereof, are agonists of G-protein coupled receptor 40 (GPR40) and may be useful in the treatment, prevention and suppression of diseases mediated by the G-protein-co

Substituted pyrazoloquinazolinones and pyrroloquinazolinones as allosteric modulators of group II metabotropic glutamate receptors

The present invention relates to the pyrazoloquinazolinone and pyrroloquinazolinone derivatives of the general formula (I), as well as pharmaceutical compositions containing them, and their use in the treatment and/or prophylaxis of conditions associated with altered glutamatergic signalling and/or functions, and/or conditions which can be affected by alteration of glutamate level or signalling in mammals, in particular their use in the treatment and/or prophylaxis of acute and chronic neurological and/or psychiatric disorders.

SUBSTITUTED PYRAZOLOQUINAZOLINONES AND PYRROLOQUINAZOLINONES AS ALLOSTERIC MODULATORS OF GROUP II METABOTROPIC GLUTAMATE RECEPTORS

The present invention relates to the pyrazoloquinazolinone and pyrroloquinazolinone derivatives of the general formula (I), as well as pharmaceutical compositions containing them, and their use in the treatment and/or prophylaxis of conditions associated with altered glutamatergic signalling and/or functions, and/or conditions which can be affected by alteration of glutamate level or signalling in mammals, in particular their use in the treatment and/or prophylaxis of acute and chronic neurological and/or psychiatric disorders.

Studies on Pyrazines. 6. A Facile Separation Method for a Mixture of the Isomeric 2-Amino-3,5, and 6-methylpyrazines

This paper describes a facile separation method for a mixture of the isomeric aminomethylpyrazines by two-stage processes.Thus the mixture of aminomethylpyrazines was converted into that of the aminobromomethylpyrazines, which could be separated by chromatography on silica gel.Each of the bromopyrazines was hydrogenated to regenerate the original aminopyrazine as a pure form.